Software Matches Genomic Test Results to Cancer Treatment Options, Including Trials and Experimental Drugs, via Intelligent Search and Molecular Science
SAN FRANCISCO, CA--(Marketwired - Mar 7, 2016) - MolecularMatch,
a personalized cancer treatment company that works with labs,
hospitals, genomic cores and physicians to connect cancer patients to
treatment options, launched its MM LAB software today at The Molecular Medicine Tri-Conference.
MM LAB,
which is available through an online portal, allows pathology labs and
others to match patients' test results to personalized cancer
treatments, including clinical trials and experimental drugs, in
real-time.
It is based on the already available, public-facing MolecularMatch cancer treatment search engine.
